{"id":2637,"date":"2022-02-02T21:39:36","date_gmt":"2022-02-02T21:39:36","guid":{"rendered":"https:\/\/grail.com\/?post_type=press-release&p=2637"},"modified":"2022-02-02T21:40:27","modified_gmt":"2022-02-02T21:40:27","slug":"grail-statement-on-president-bidens-bold-initiative-to-reignite-the-cancer-moonshot","status":"publish","type":"press-release","link":"https:\/\/grail.com\/press-releases\/grail-statement-on-president-bidens-bold-initiative-to-reignite-the-cancer-moonshot\/","title":{"rendered":"GRAIL Statement on President Biden\u2019s Bold Initiative to Reignite the Cancer Moonshot"},"content":{"rendered":"

Josh Ofman, MD, MSHS, president and chief medical officer of GRAIL, LLC, issued the following statement:<\/em><\/p>\n

MENLO PARK, Calif., February 2, 2022 \u2013 \u201cWe applaud President Biden for reigniting the Cancer Moonshot and highlighting the critical role of early detection in achieving the ambitious, but attainable, goal of reducing the cancer death rate by at least 50 percent in the next 25 years. Improving quality of life for patients and survivors, while addressing inequities in access to cancer screening, diagnostics and treatment is a critical part of the plan. Importantly, the President\u2019s plan recognizes that the rigorous study of multi-cancer detection blood tests, to date, has brought us to a crucial inflection point where detecting many cancers at once is now an essential pillar of any effort to end cancer as we know it today.\u201d<\/p>\n

\u201cGRAIL is deeply committed to detecting cancer early when treatments are more effective and there is potential for cure. Recent research has estimated the impact of multi-cancer early detection (MCED) testing on the ability to find more cancer types, in earlier stages, potentially reducing cancer deaths. We stand ready to accelerate the President\u2019s bold plan and believe that MCED tests will help make it possible.<\/p>\n

\u201cIn partnership with preeminent cancer institutions across the country, we validated the science behind our MCED technology and, in 2021, introduced Galleri\u00ae<\/sup><\/strong> as a prescription only test for adults with an elevated risk of cancer, including those age 50 and older. As a result, today, we can detect more than 50 types of cancer, including in early stages, using a simple blood draw, vastly expanding the benefits of screening to more cancers and more people. We look forward to continuing our evidence generation with scientific and clinical partners and engaging with policymakers and the cancer stakeholder community so that more Americans can benefit from this paradigm shift in early cancer detection.\u201d<\/p>\n

 <\/p>\n

About GRAIL<\/strong>
\nGRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by developing pioneering technology to detect and identify multiple deadly cancer types early. The company is using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art computer science and data science to enhance the scientific understanding of cancer biology, and to develop its multi-cancer early detection blood test. GRAIL is headquartered in Menlo Park, CA with locations in Washington, D.C., North Carolina, and the United Kingdom. GRAIL, LLC, is a wholly-owned subsidiary of Illumina, Inc. (NASDAQ:ILMN). For more information, please visit www.grail.com<\/a>.<\/p>\n

About Galleri<\/strong>
\nThe earlier that cancer is detected, the higher the chance of successful outcomes. The Galleri multi-cancer early detection test can detect more than 50 types of cancer, as defined by the American Joint Committee on Cancer Staging Manual, through a routine blood draw. When a cancer signal is detected, the Galleri test predicts the cancer signal origin, or where the cancer is located in the body, with high accuracy to help guide the next steps to diagnosis. The Galleri test requires a prescription from a licensed healthcare provider and should be used in addition to recommended cancer screenings such as mammography, colonoscopy, prostate-specific antigen (PSA) test, or cervical cancer screening. It is intended for use in people with an elevated risk of cancer, such as those aged 50 or older.<\/p>\n

For more information about Galleri, visit www.galleri.com<\/a>.<\/p>\n


\nImportant Galleri Safety Information<\/strong>
\nThe Galleri test is recommended for use in adults with an elevated risk for cancer, such as those aged 50 or older. The Galleri test does not detect all cancers and should be used in addition to routine cancer screening tests recommended by a healthcare provider. Galleri is intended to detect cancer signals and predict where in the body the cancer signal is located. Use of Galleri is not recommended in individuals who are pregnant, 21 years old or younger, or undergoing active cancer treatment.<\/p>\n

Results should be interpreted by a healthcare provider in the context of medical history, clinical signs and symptoms. A test result of \u201cCancer Signal Not Detected\u201d does not rule out cancer. A test result of \u201cCancer Signal Detected\u201d requires confirmatory diagnostic evaluation by medically established procedures (e.g. imaging) to confirm cancer.<\/p>\n

If cancer is not confirmed with further testing, it could mean that cancer is not present or testing was insufficient to detect cancer, including due to the cancer being located in a different part of the body. False-positive (a cancer signal detected when cancer is not present) and false-negative (a cancer signal not detected when cancer is present) test results do occur. Rx only.<\/p>\n","protected":false},"excerpt":{"rendered":"

Josh Ofman, MD, MSHS, president and chief medical officer of GRAIL, LLC, issued the following statement: MENLO PARK, Calif., February 2, 2022 \u2013 \u201cWe applaud President Biden for reigniting the Cancer Moonshot and highlighting the critical role of early detection in achieving the ambitious, but attainable, goal of reducing the cancer death rate by at […]<\/p>\n","protected":false},"featured_media":1303,"parent":0,"menu_order":0,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-2637","press-release","type-press-release","status-publish","format-standard","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"\nGRAIL Statement on President Biden\u2019s Bold Initiative to Reignite the Cancer Moonshot - GRAIL<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/grail.com\/press-releases\/grail-statement-on-president-bidens-bold-initiative-to-reignite-the-cancer-moonshot\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GRAIL Statement on President Biden\u2019s Bold Initiative to Reignite the Cancer Moonshot - GRAIL\" \/>\n<meta property=\"og:description\" content=\"Josh Ofman, MD, MSHS, president and chief medical officer of GRAIL, LLC, issued the following statement: MENLO PARK, Calif., February 2, 2022 \u2013 \u201cWe applaud President Biden for reigniting the Cancer Moonshot and highlighting the critical role of early detection in achieving the ambitious, but attainable, goal of reducing the cancer death rate by at […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/grail.com\/press-releases\/grail-statement-on-president-bidens-bold-initiative-to-reignite-the-cancer-moonshot\/\" \/>\n<meta property=\"og:site_name\" content=\"GRAIL\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/grailbio\/\" \/>\n<meta property=\"article:modified_time\" content=\"2022-02-02T21:40:27+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/grail.com\/wp-content\/uploads\/2020\/12\/Mask-Group-26@2x-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"423\" \/>\n\t<meta property=\"og:image:height\" content=\"172\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@grailbio\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/grail.com\/press-releases\/grail-statement-on-president-bidens-bold-initiative-to-reignite-the-cancer-moonshot\/\",\"url\":\"https:\/\/grail.com\/press-releases\/grail-statement-on-president-bidens-bold-initiative-to-reignite-the-cancer-moonshot\/\",\"name\":\"GRAIL Statement on President Biden\u2019s Bold Initiative to Reignite the Cancer Moonshot - GRAIL\",\"isPartOf\":{\"@id\":\"https:\/\/grail.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/grail.com\/press-releases\/grail-statement-on-president-bidens-bold-initiative-to-reignite-the-cancer-moonshot\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/grail.com\/press-releases\/grail-statement-on-president-bidens-bold-initiative-to-reignite-the-cancer-moonshot\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/assets.grail.com\/wp-content\/uploads\/2020\/12\/Mask-Group-26%402x-1.jpg\",\"datePublished\":\"2022-02-02T21:39:36+00:00\",\"dateModified\":\"2022-02-02T21:40:27+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/grail.com\/press-releases\/grail-statement-on-president-bidens-bold-initiative-to-reignite-the-cancer-moonshot\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/grail.com\/press-releases\/grail-statement-on-president-bidens-bold-initiative-to-reignite-the-cancer-moonshot\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/grail.com\/press-releases\/grail-statement-on-president-bidens-bold-initiative-to-reignite-the-cancer-moonshot\/#primaryimage\",\"url\":\"https:\/\/assets.grail.com\/wp-content\/uploads\/2020\/12\/Mask-Group-26%402x-1.jpg\",\"contentUrl\":\"https:\/\/assets.grail.com\/wp-content\/uploads\/2020\/12\/Mask-Group-26%402x-1.jpg\",\"width\":423,\"height\":172},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/grail.com\/press-releases\/grail-statement-on-president-bidens-bold-initiative-to-reignite-the-cancer-moonshot\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/grail.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GRAIL Statement on President Biden\u2019s Bold Initiative to Reignite the Cancer Moonshot\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/grail.com\/#website\",\"url\":\"https:\/\/grail.com\/\",\"name\":\"GRAIL\",\"description\":\"Detect cancer early, when it can be cured\",\"publisher\":{\"@id\":\"https:\/\/grail.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/grail.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/grail.com\/#organization\",\"name\":\"GRAIL, LLC\",\"url\":\"https:\/\/grail.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/grail.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/assets.grail.com\/wp-content\/uploads\/2021\/01\/cropped-favicon-G.png\",\"contentUrl\":\"https:\/\/assets.grail.com\/wp-content\/uploads\/2021\/01\/cropped-favicon-G.png\",\"width\":512,\"height\":512,\"caption\":\"GRAIL, LLC\"},\"image\":{\"@id\":\"https:\/\/grail.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/grailbio\/\",\"https:\/\/x.com\/grailbio\",\"https:\/\/www.linkedin.com\/company\/grail-inc.\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"GRAIL Statement on President Biden\u2019s Bold Initiative to Reignite the Cancer Moonshot - GRAIL","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/grail.com\/press-releases\/grail-statement-on-president-bidens-bold-initiative-to-reignite-the-cancer-moonshot\/","og_locale":"en_US","og_type":"article","og_title":"GRAIL Statement on President Biden\u2019s Bold Initiative to Reignite the Cancer Moonshot - GRAIL","og_description":"Josh Ofman, MD, MSHS, president and chief medical officer of GRAIL, LLC, issued the following statement: MENLO PARK, Calif., February 2, 2022 \u2013 \u201cWe applaud President Biden for reigniting the Cancer Moonshot and highlighting the critical role of early detection in achieving the ambitious, but attainable, goal of reducing the cancer death rate by at […]","og_url":"https:\/\/grail.com\/press-releases\/grail-statement-on-president-bidens-bold-initiative-to-reignite-the-cancer-moonshot\/","og_site_name":"GRAIL","article_publisher":"https:\/\/www.facebook.com\/grailbio\/","article_modified_time":"2022-02-02T21:40:27+00:00","og_image":[{"width":423,"height":172,"url":"http:\/\/grail.com\/wp-content\/uploads\/2020\/12\/Mask-Group-26@2x-1.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@grailbio","twitter_misc":{"Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/grail.com\/press-releases\/grail-statement-on-president-bidens-bold-initiative-to-reignite-the-cancer-moonshot\/","url":"https:\/\/grail.com\/press-releases\/grail-statement-on-president-bidens-bold-initiative-to-reignite-the-cancer-moonshot\/","name":"GRAIL Statement on President Biden\u2019s Bold Initiative to Reignite the Cancer Moonshot - GRAIL","isPartOf":{"@id":"https:\/\/grail.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/grail.com\/press-releases\/grail-statement-on-president-bidens-bold-initiative-to-reignite-the-cancer-moonshot\/#primaryimage"},"image":{"@id":"https:\/\/grail.com\/press-releases\/grail-statement-on-president-bidens-bold-initiative-to-reignite-the-cancer-moonshot\/#primaryimage"},"thumbnailUrl":"https:\/\/assets.grail.com\/wp-content\/uploads\/2020\/12\/Mask-Group-26%402x-1.jpg","datePublished":"2022-02-02T21:39:36+00:00","dateModified":"2022-02-02T21:40:27+00:00","breadcrumb":{"@id":"https:\/\/grail.com\/press-releases\/grail-statement-on-president-bidens-bold-initiative-to-reignite-the-cancer-moonshot\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/grail.com\/press-releases\/grail-statement-on-president-bidens-bold-initiative-to-reignite-the-cancer-moonshot\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/grail.com\/press-releases\/grail-statement-on-president-bidens-bold-initiative-to-reignite-the-cancer-moonshot\/#primaryimage","url":"https:\/\/assets.grail.com\/wp-content\/uploads\/2020\/12\/Mask-Group-26%402x-1.jpg","contentUrl":"https:\/\/assets.grail.com\/wp-content\/uploads\/2020\/12\/Mask-Group-26%402x-1.jpg","width":423,"height":172},{"@type":"BreadcrumbList","@id":"https:\/\/grail.com\/press-releases\/grail-statement-on-president-bidens-bold-initiative-to-reignite-the-cancer-moonshot\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/grail.com\/"},{"@type":"ListItem","position":2,"name":"GRAIL Statement on President Biden\u2019s Bold Initiative to Reignite the Cancer Moonshot"}]},{"@type":"WebSite","@id":"https:\/\/grail.com\/#website","url":"https:\/\/grail.com\/","name":"GRAIL","description":"Detect cancer early, when it can be cured","publisher":{"@id":"https:\/\/grail.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/grail.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/grail.com\/#organization","name":"GRAIL, LLC","url":"https:\/\/grail.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/grail.com\/#\/schema\/logo\/image\/","url":"https:\/\/assets.grail.com\/wp-content\/uploads\/2021\/01\/cropped-favicon-G.png","contentUrl":"https:\/\/assets.grail.com\/wp-content\/uploads\/2021\/01\/cropped-favicon-G.png","width":512,"height":512,"caption":"GRAIL, LLC"},"image":{"@id":"https:\/\/grail.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/grailbio\/","https:\/\/x.com\/grailbio","https:\/\/www.linkedin.com\/company\/grail-inc.\/"]}]}},"_links":{"self":[{"href":"https:\/\/grail.com\/wp-json\/wp\/v2\/press-release\/2637","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/grail.com\/wp-json\/wp\/v2\/press-release"}],"about":[{"href":"https:\/\/grail.com\/wp-json\/wp\/v2\/types\/press-release"}],"version-history":[{"count":0,"href":"https:\/\/grail.com\/wp-json\/wp\/v2\/press-release\/2637\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/grail.com\/wp-json\/wp\/v2\/media\/1303"}],"wp:attachment":[{"href":"https:\/\/grail.com\/wp-json\/wp\/v2\/media?parent=2637"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}